Results 171 to 180 of about 4,563 (204)

Pharmacological Characterization of GPR55, a Putative Cannabinoid Receptor [PDF]

open access: yesPharmacology & Therapeutics, 2010
GPR55 has recently attracted much attention as another member of the cannabinoid family, potentially explaining physiological effects that are non-CB1/CB2 mediated. However, the data gathered so far are conflicting with respect to its pharmacology. We review the primary literature to date on GPR55, describing its discovery, structure, pharmacology and ...
Mary E. Abood, Haleli Sharir
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Is GPR55 an anandamide receptor?

Vitamins and hormones, 2009
Anandamide activates CB(1) cannabinoid receptors but also has effects, particularly in the vasculature, that cannot be explained by actions at either this or the other cloned cannabinoid receptor, the CB(2) receptor. These effects are probably mediated by a novel G protein-coupled receptor, but genome searching has not revealed a strong candidate ...
Andrew J, Brown, C, Robin Hiley
openaire   +3 more sources

GPR55 and the regulation of glucose homeostasis

The International Journal of Biochemistry & Cell Biology, 2017
Pathophysiological conditions such as obesity and type 2 diabetes (T2D) are reportedly associated to over-activation of the endocannabinoid system (ECS). Therefore, modulation of the ECS offers potential therapeutic benefits on those diseases. GPR55, the receptor for L-α-lysophosphatidylinositol (LPI) that has also affinity for various cannabinoid ...
Eva, Tudurí   +4 more
openaire   +2 more sources

GPR55

2018
G protein-coupled receptor 55 (GPR55) was first cloned in 1999 and is a 319 amino acid seven transmembrane G protein-coupled receptor (GPCR) that is mapped to chromosome 2q37 (human) (Sawzdargo et al. 1999). It displays features common with other Family A GPCRs including a short extracellular N-terminal and C-terminal tail and contains two highly ...
A. C. Simcocks   +5 more
openaire   +2 more sources

Advances in the Physiology of GPR55 in the Central Nervous System [PDF]

open access: yesCurrent Neuropharmacology, 2017
The G protein-coupled receptor 55 (GPR55) is a mammalian orphan receptor that awaits a formal classification. There are an increasing number of reports directed to know the physiology and pathophysiology of this receptor. Lamentably, its functions in the central nervous system (CNS) have been scarcely elucidated.A bibliographic search in PubMed ...
Mónica Méndez-Diaz   +2 more
exaly   +3 more sources

GPR55 in the CNS

2012
The identification of GPR55 as a possible cannabinoid receptor generated a flurry of interest as based on the hope that this receptor might explain some of the non-CB1/CB2/TRPV1 effects of cannabinoid compounds. However, it rapidly became clear that the pharmacology and signaling of GPR55 were quite complicated.
Hui-Chen Lu   +3 more
openaire   +1 more source

The enigmatic pharmacology of GPR55

Trends in Pharmacological Sciences, 2009
Preliminary data presented at conferences and in the patent literature introduced the possibility the orphan receptor GPR55 might account for some of the well-documented non-CB(1), non-CB(2) effects reported for certain cannabinoid ligands. Several peer-reviewed publications have recently emerged in which the pharmacology of the cannabinoids at GPR55 ...
openaire   +2 more sources

GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?

Current Topics in Medicinal Chemistry, 2010
Emerging data indicates the existence of novel molecular targets for cannabinoid ligands and recently it has been suggested that the orphan G-protein coupled receptor, GPR55 can be activated by a range of endogenous, plant and synthetic cannabinoids.
Nevalainen, Tapio, Irving, Andrew J.
openaire   +2 more sources

The Role of GPR55 in Cancer

2012
Evidence accumulated during the last few years suggests that GPR55 is an important component of the molecular circuitry that controls cancer cell behavior. As will be described in this chapter, this receptor has been directly or indirectly related to the basic alterations that drive malignant growth: uncontrolled cancer cell proliferation, sustained ...
Clara Andradas   +4 more
openaire   +1 more source

GPR55 Ligands Promote Receptor Coupling to Multiple Signalling Pathways

open access: yesBritish Journal of Pharmacology, 2010
Background and purpose:Although GPR55 is potently activated by the endogenous lysophospholipid, L-alpha-lysophosphatidylinositol (LPI), it is also thought to be sensitive to a number of cannabinoid ligands, including the prototypic CB1 receptor ...
Christopher M Henstridge   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy